Evidence map›Paper›PMID 30034763›Full record

ArticleChemical science2016

Self-assembly of gold supraparticles with crystallographically aligned and strongly coupled nanoparticle building blocks for SERS and photothermal therapy.

S Paterson, S A Thompson, J Gracie, A W Wark, R de la Rica

Abstract read
In one paragraph

Article in Chemical science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

S PatersonDepartment of Pure and Applied Chemistry , WestCHEM , University of Strathclyde , Technology and Innovation Centre , 99 George Street , Glasgow , G1 1RD , Scotland , UK . Email: roberto.delarica@strath.ac.uk.
S A ThompsonDepartment of Pure and Applied Chemistry , WestCHEM , University of Strathclyde , Technology and Innovation Centre , 99 George Street , Glasgow , G1 1RD , Scotland , UK . Email: roberto.delarica@strath.ac.uk.
J GracieDepartment of Pure and Applied Chemistry , WestCHEM , University of Strathclyde , Technology and Innovation Centre , 99 George Street , Glasgow , G1 1RD , Scotland , UK . Email: roberto.delarica@strath.ac.uk.
A W WarkDepartment of Pure and Applied Chemistry , WestCHEM , University of Strathclyde , Technology and Innovation Centre , 99 George Street , Glasgow , G1 1RD , Scotland , UK . Email: roberto.delarica@strath.ac.uk.ORCID 0000-0001-8736-7566
R de la RicaDepartment of Pure and Applied Chemistry , WestCHEM , University of Strathclyde , Technology and Innovation Centre , 99 George Street , Glasgow , G1 1RD , Scotland , UK . Email: roberto.delarica@strath.ac.uk.ORCID 0000-0002-5750-1469

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new method is introduced for self-assembling citrate-capped gold nanoparticles into supraparticles with crystallographically aligned building blocks. It consists in confining gld nanoparticles inside a cellulose acetate membrane. The constituent nanoparticles are in close contact in the superstructure, and therefore generate hot spots leading to intense Surface-Enhanced Raman Scattering (SERS) signals. They also generate more plasmonic heat than the nanoparticle building blocks. The supraparticles are internalized by cells and show low cytotoxicity, but can kill cancer cells when irradiated with a laser. This, along with the improved plasmonic properties arising from their assembly, makes the gold supraparticles promising materials for applications in bioimaging and nanomedicine.

Identifiers

PMID30034763
PMCPMC6024203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.